Treatment and Prevention of Heparin-Induced Thrombocytopenia Lori-Ann Linkins, MD, Antonio L. Dans, MD, Lisa K. Moores, MC, USA, FCCP, Robert Bona, MD, Bruce L. Davidson, MD, MPH, FCCP, Sam Schulman, MD, PhD, Mark Crowther, MD CHEST Volume 141, Issue 2, Pages e495S-e530S (February 2012) DOI: 10.1378/chest.11-2303 Copyright © 2012 The American College of Chest Physicians Terms and Conditions
Figure 1 4Ts score. *Timing of clinical sequelae, such as thrombocytopenia, thrombosis, or skin lesions. **Two points if necrotizing heparin-induced skin lesions even if thrombocytopenia not present. (Modified with permission from Warkentin and Linkins.59) CHEST 2012 141, e495S-e530SDOI: (10.1378/chest.11-2303) Copyright © 2012 The American College of Chest Physicians Terms and Conditions